Skip to main content
SpringerLink
Log in

Maligne Lymphome

  • Chapter
Book cover Standardisierte Krebsbehandlung

  • 27 Accesses

Zusammenfassung

Die Ätiologie der HL ist noch ungeklärt. Relevante Vorkrankheiten, die zum HL disponieren, sind bisher unbekannt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Bagley C Jr, de Vita MT, Berard CW, Canellos GP (1972) Advanced lymphosarcoma: Intensive cyclical combination chemotherapy with Cyclophosphamide, Vincristine and Prednisone. Ann Intern Med 76:227–234

    PubMed  Google Scholar 

  • Bonadonna G, Uslenghi C, Zucali R (1975 a) Recent trends in the medical treatment of Hodgkin’s disease. Eur J Cancer 11:251

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975 b) Combination chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36:252

    Article  PubMed  CAS  Google Scholar 

  • Bonadonna G, Zucali R, De Lena M, Valagussa P (1977) Combined chemotherapy (MOPP or ABVD)- radiotherapy approach in advanced Hodgkin’s disease. Cancer Treat Rep 61:769

    PubMed  CAS  Google Scholar 

  • Brucher H (1978) Chemotherapie der malignen Lymphome. Med Welt 29:1563

    PubMed  CAS  Google Scholar 

  • Brunner KW, Maurice P, Sonntag RW (1973) CCNU (l-(2-Chloroethyl)-3-cyclohexyl-l-nitrosourea) und BCNU (l,3-Bis-(2-chloroethyl)-l-nitrosourea) sowie BCNU-Kombinationen beim Lymphogranuloma Hodgkin Stadium III und IV. In: Stacher A (Hrsg) Leukamien und maligne Lymphome. Urban &Schwarzenberg, München Berlin Wien

    Google Scholar 

  • Brunner KW, Nagel GA (1976) (Hrsg) Internistische Krebstherapie. Springer, Berlin Heidelberg New York

    Google Scholar 

  • Carbone PP, Kaplan HS, Musshoff K et al. (1971) Report of the comittee on Hodgkin’s disease staging classification. Cancer Res 31:1860–1861

    PubMed  CAS  Google Scholar 

  • Chaffey JT, Rosenthal DS, Pinkus G, Hellmann A (1975) Advanced lymphosarcoma, treated by total body irradiation. Br J Cancer [Suppl] 11:441

    Google Scholar 

  • Cox JD, Koehl RH, Turner WM, King FM (1974) Irradiation in the local control of malignant lymphoreticular tumors (non-Hodgkin’s malignant lymphoma). Radiology 112:179

    PubMed  CAS  Google Scholar 

  • De Vita VT, Serpick A, Carbone PP (1970) Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann Intern Med 73:881

    Google Scholar 

  • De Vita VT, Simon RM, Hubbard SM et al. (1980) Curability of advanced Hodgkin’s disease with chemotherapy: long-term follow-up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92:587

    Google Scholar 

  • Dorken H (1978) Zur Epidemiologic des Morbus Hodgkin. Klinikarzt 7:685

    Google Scholar 

  • Engelhardt R (1978) Maligne Lymphome. In: Fetzer J, Fullenbach D, Gabel H (Hrsg) Adriamycin Bd 2. Solide Tumoren und Hamoblastosen. Neue Moglichkeiten der Chemotherapie. Round-Ta- ble Gesprache Januar 1977 bis November 1977: Kehrer, Freiburg

    Google Scholar 

  • Fischer W, Folsch E (1975) Wandlungen der Diagnose und Therapie des Lymphosarcoms und Reticulosarcoms. Dtsch Med Wochenschr 100:630

    Article  PubMed  CAS  Google Scholar 

  • Fischer J, Preiss J (1978) Staging maligner Lymphome. Klinikarzt 7:708

    Google Scholar 

  • Gallmeier WM, Bruntsch U (1981) Die Chemotherapie des Morbus Hodgkin. Internist 22:289

    PubMed  CAS  Google Scholar 

  • Glatstein E, Donaldson SS, Rosenberg SA, Kaplan HS (1977) Combined modality therapy in malignant lymphomas. Cancer Treat Rep 61:1199

    Google Scholar 

  • Grace JT, Mittelmann A (1966) Surgery in the management of Hodgkin’s disease. Cancer 19:351–355

    Article  Google Scholar 

  • Gross R, Bredenbrocker H, Schmidt CG, Zach J (1981) Klinik und Prognostik des Morbus Hodgkin. Eine Studie anhand von 1200 eigenen Fallen. Internist 22:264

    PubMed  CAS  Google Scholar 

  • Hartwich G (1978) Chemotherapie der malignen Lymphome. Klinikarzt 7:915

    Google Scholar 

  • Herman TS, Jones SE (1978) Systematic restaging in patients with Hodgkin’s disease: a southwest oncology group study. Cancer 42:1976

    Article  PubMed  CAS  Google Scholar 

  • Horton J (1977) The lymphomas. In: Horton J, Hill GJ (eds) Clinical oncology. Saunders, Philadelphia

    Google Scholar 

  • Jackson H, Parker F (1947) Hodgkin’s disease and allied disorders. Oxford University Press, New York

    Google Scholar 

  • Jones SE, Fuks Z, Bull M et al. (1973) Non-Hodgkin’s lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer 31:806

    Article  PubMed  CAS  Google Scholar 

  • Kaiserling E (1978) Klassifikation der malignen Lymphome. Klinikarzt 7:689

    Google Scholar 

  • Lauria F, Baccarani M, Fiacchini MG, Tura S (1975) Methotrexate, cyclophosphamide and vincristine (MEV-regimen) for non Hodgkin’s lymphomas. Eur J Cancer 11:343

    Article  PubMed  CAS  Google Scholar 

  • Lennert K (1978) Malignant lymphomas other than Hodgkin’s disease. Springer, Berlin Heidelberg New York (Handbuch der speziellen pathologischen Anatomie und Histologic, Bd 1/3B)

    Book  Google Scholar 

  • Luce JK, Frei E III, Gehan EA, Coltman CHA Jr, Talley R, Monto RW (1973) Chemotherapy of Hodgkin’s disease. Arch Intern Med 131:391

    Article  PubMed  CAS  Google Scholar 

  • Lukes RJ, Craver LL, Hall TC, Rappaport H, Rubin P (1966 a) Hodgkin’s disease, report of Nomenclature Committee. Cancer Res 26:1311

    Google Scholar 

  • Lukes RJ, Butler JJ, Hicks EB (1966 b) Natural history of Hodgkin’s disease as related to its pathologic picture. Cancer 10:317–344

    Article  Google Scholar 

  • McKelvey EM, Gottlieb J A, Wilson HE et al. (1976) Hydroxyldannomycin (Adriamycin) combination chemotherapy in malignant lymphoma. Cancer 38:1484

    Article  PubMed  CAS  Google Scholar 

  • Moxley JH III, de Vita T, Brace K, Frei E III (1967) Intensive combination chemotherapy and x-irradiation in Hodgkin’s disease. Cancer Res 27:1258

    PubMed  Google Scholar 

  • Musshoff K (1972) Grundlagen der Strahlentherapie des Morbus Hodgkin. Indikation und Ergebnisse. Z Krebsforsch 78:162

    Article  CAS  Google Scholar 

  • Musshoff K (1978) Die Strahlentherapie der malignen Lymphome. Klinikarzt 7:894

    Google Scholar 

  • Musshoff K, Boutis L (1969) Die Behandlungsergebnisse der malignen Lymphogranulomatose (Morbus Hodgkin) in Abhangigkeit von individuellen und krankheitsspezifischen Faktoren und der Therapie. Klin Wochenschr 47:93–101

    Article  PubMed  CAS  Google Scholar 

  • Musshoff K, Slamina J (1974) Die Strahlenbehandlung der Lymphogranulomatose. Internist 15:85

    PubMed  CAS  Google Scholar 

  • Musshoff K, Schmidt-Vollmer H (1975) Prognosis of non-Hodgkin’s lymphomas with special emphasis on the staging classification. Z Krebsforsch 83:323

    Article  CAS  Google Scholar 

  • Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG (1976) Post-MOPP-chemotherapie des M. Hodgkin. Dtsch Med Wochenschr 101:1177

    Article  PubMed  CAS  Google Scholar 

  • Rappaport H (1966) Tumors of the hematopoietic system. Armed Forces Institute of Pathology, Washington (Atlas of tumor pathology III/8) Rosenberg SA (1966) Report of the committee on the staging of Hodgkin’s disease. Cancer Res 26:1310

    Google Scholar 

  • Rosenberg SA, Kaplan HS, Brown BW (1979) The role of adjuvant MOPP in the therapy of Hodgkin’s disease: an analysis after ten years. In: Jones SE, Salmon SE (eds) Adjuvant therapy of cancer II. Grune&Stratton, New York

    Google Scholar 

  • Santoro A, Bonadonna G, Bonfante V, Valagussa P (1980) Non cross resistant regimes (MOPP and ABVD) VS MOPP alone in stage IV Hodgkin’s disease (HD). Proc Am Soc Clin Oncol 21:470

    Google Scholar 

  • Stein RS, Golomb HM, Ultmann JE, Wiernik PH, Diggs C, Hellman S, Mauch P (1979) Anatomic substages of stage III Hodgkin’s disease (HD): a collaborative study. Proc Am Soc Clin Oncol 20:438

    Google Scholar 

  • Swan HT, Knowelden J (1971) Prognosis in Hodgkin’s disease related to Lymphocyte Count. Br J Haematol 21:343–349

    Article  PubMed  CAS  Google Scholar 

  • Ziegler JL, Magrath IT, Deisseroth AB et al. (1978) Combined modality treatment of Burkitt’s lymphoma. Cancer Treat Rep 62:2031

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Fritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Kuttig
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Evangelisches Krankenhaus, Waldstraße 73, D-5300, Bonn-Bad Godesberg, Deutschland

    Gerhard Ott

  2. Universitäts-Strahlenklinik, Voßstraße 3, D-6900, Heidelberg, Deutschland

    Helmut Kuttig

  3. Klinik für Thoraxerkrankungen der Landesversicherungsanstalt Baden, Krankenhaus Rohrbach, Amalienstraße 5, D-6900, Heidelberg, Deutschland

    Peter Drings

Rights and permissions

Reprints and permissions

Copyright information

© 1982 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Fritsch, H., Kuttig, H. (1982). Maligne Lymphome. In: Ott, G., Kuttig, H., Drings, P. (eds) Standardisierte Krebsbehandlung. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88238-8_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-88238-8_36

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-88239-5

  • Online ISBN: 978-3-642-88238-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation